Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance

Table 1

Age- and gender-specific prevalence of metabolic syndrome in Estonia.

Age–group	𝑛	% (95% CI)
20–44 years (𝑛=221)	42	19.0 (14.2–24.9)
Men (𝑛=105)	27	25.7 (17.9–35.3)
Women (𝑛=116)	15	12.9 (7.7–20.7)
45–60 years (𝑛=163)	46	28.2 (21.6–35.9)
Men (𝑛=64)	19	29.7 (19.2–42.6)
Women (𝑛=99)	27	27.3 (19.0–37.3)
61–74 years (𝑛=111)	50	45.0 (35.7–54.8)
Men (𝑛=45)	20	44.4 (30.0–59.9)
Women (𝑛=66)	30	45.5 (33.3–58.1)
Total (𝑛=495)	138	27.9 (24.0–32.1)
Men (𝑛=214)	66	30.8 (24.8–37.6)
Women (𝑛=281)	72	25.6 (20.7–31.2)